Updated · AI-assisted evidence analysis
PetAmaze Joint Care Daily Chews Review 2026: What Does the Evidence Show?
Real joint ingredients, but no proof this chew works as claimed — Overhyped
-
"Reduces inflammation and discomfort (fish oil)"
A placebo-controlled dog trial found less discomfort and lameness at 84 days, using an average of 69 mg EPA+DHA per kg daily. The label lists 200 mg of Incromega fish oil per 2 chews, not EPA+DHA, so the dose check was not comparable and the label amount can't be matched to the study amount.
A prospective, randomized, double blind, placebo-controlled evaluation of the effects of eicosapentaenoic acid and docosahexaenoic acid on the clinical signs and erythrocyte membrane polyunsaturated fatty acid concentrations in dogs with osteoarthritis. → · PetAmaze Joint Care Daily Chews: manufacturer product page → -
"Green-lipped mussel is 'clinically shown' to help dogs"
Some placebo-controlled dog trials favoured mussel products, but they used different products and doses. One mussel/curcumin blend did not beat placebo. The page names no study, and none tested this chew.
Evaluating Complementary Therapies for Canine Osteoarthritis Part I: Green-lipped Mussel (Perna canaliculus). → · Clinical efficacy and tolerance of an extract of green-lipped mussel (Perna canaliculus) in dogs presumptively diagnosed with degenerative joint disease. → · Evaluation of the comparative efficacy of green lipped mussel plus krill oil extracts (EAB-277), <i>Biota orientalis</i> extracts or NSAIDs for the treatment of dogs with osteoarthritis associated pain: a blinded, placebo-controlled study. → · The efficacy of a nutritional supplement containing green-lipped mussel, curcumin and blackcurrant leaf extract in dogs and cats with osteoarthritis. → · PetAmaze Joint Care Daily Chews: manufacturer product page → -
"Glucosamine and chondroitin protect cartilage"
A 2022 review pooling dog and cat trials found chondroitin-glucosamine products showed a very marked non-effect on pain, and said no treatment has shown it slows arthritis. The review does not separate dog-only results in the text we had. Cartilage protection is not established.
-
"Turmeric and Kynosil support joints"
A turmeric extract trial in dogs showed no force-plate difference from placebo. No dog joint study of Kynosil or PureFlax was found in this search.
Claims vs Evidence
4 claims assessed. Support depends on the study results, formulation, and population. Matching an ingredient or dose alone does not establish a benefit.
"Protects cartilage and joint tissue"
Stretch
Only a small abstract-only trial of a different mussel extract reported cartilage findings. A 2022 review that pooled dogs and cats found a very marked non-effect of chondroitin-glucosamine on pain and said no approach has shown it slows OA progression; because it pools species, it is not used as a dog evidence row. Mussel evidence is partial at best.
PCSO-524 in dogs with patellar luxation OA
Placebo-controlled trial with a healthy reference group; abstract only · ingredient
Reported better lameness scores, ultrasound cartilage lesions, synovial fluid scores and mild radiographic improvement vs placebo progression; no blood or organ adverse effects reported.
Limitations: Very small groups, abstract only, one product and breed type, not this formulation; effect sizes and methods unavailable.
- Species
- dog
- Participants / condition
- 25 dogs total: 21 with medial patellar luxation grade II (50 stifles), 4 healthy reference dogs; small breeds (Pomeranian, Chihuahua)
- Formulation
- PCSO-524 green-lipped mussel extract, a different product from this chew
- Studied amount, not dosing advice
- 50 mg daily (study description)
- Duration
- 16 weeks
- Funding / conflicts
- Not reported in retrieved text
"Reduces inflammation and discomfort"
Stretch
Fish oil has the best dog evidence, but the studied amount (69 mg EPA+DHA per kg per day) can't be directly compared with this label, which lists fish oil rather than EPA+DHA (dose check not comparable). Mussel evidence is partial, and turmeric is weak. No inflammation markers were tested for this product.
EPA and DHA in dogs with OA
Prospective, randomized, double-blind, placebo-controlled trial · ingredient
Discomfort, lameness and joint severity at day 84 and blood fatty-acid measures improved vs placebo; no major side effects.
Limitations: Abstract only; single oil product; label gives fish oil weight, not EPA+DHA, so amounts are not directly comparable.
- Species
- dog
- Participants / condition
- 78 client-owned dogs with hip and/or stifle OA; 74 completed
- Formulation
- Triglyceride n-3 oil vs placebo oil, not a chew
- Studied amount, not dosing advice
- Average 69 mg EPA+DHA per kg per day (study description)
- Duration
- 84 days
- Funding / conflicts
- Listed as non-US government research support; conflicts not reported in retrieved text
P54FP turmeric extract in dogs with OA
Randomised, double-blind, placebo-controlled trial · ingredient
No group difference in force-plate peak vertical force; investigators' overall rating favoured treatment (P=0.012); owners' rating just missed significance (P=0.063).
Limitations: Abstract only; different extract; objective measure showed no benefit.
- Species
- dog
- Participants / condition
- 61 client-owned dogs with elbow or hip OA; 25 treated and 29 placebo dogs analysed
- Formulation
- P54FP turmeric extract, not turmeric root powder in a chew
- Studied amount, not dosing advice
- Twice daily; mg amount not reported in abstract
- Duration
- 8 weeks
- Funding / conflicts
- Listed as non-US government research support; conflicts not reported in retrieved text
Mussel plus krill oil (EAB-277) vs placebo and meloxicam
Prospective, block-randomized, double-blind, placebo-controlled, four-arm trial · ingredient
Force-plate peak vertical force and orthopedic scores improved more than placebo, similar to meloxicam.
Limitations: Different product with krill oil; six-week follow-up; dose unavailable.
- Species
- dog
- Participants / condition
- 101 pet dogs with hip OA pain
- Formulation
- Antinol Rapid (green-lipped mussel plus krill oil extracts), not this chew
- Studied amount, not dosing advice
- Not reported in the retrieved excerpt
- Duration
- 6 weeks
- Funding / conflicts
- Funded by Pharmalink International Ltd; authors state the funder was not involved in design, analysis or writing
"Improves mobility, flexibility and movement"
Partial
Green-lipped mussel trials in dogs with OA mostly showed better mobility or pain scores vs placebo, though effects were modest or late and one blend found no benefit. Products and doses differ from this chew, so the finished product is unproven.
Green-lipped mussel vs placebo and carprofen
Randomized, double-blind, placebo- and positive-controlled trial · ingredient
More GLM dogs improved than placebo on veterinary mobility, owner pain index and pain scale; less effective than carprofen.
Limitations: Abstract only; dose unavailable; only some outcomes significant.
- Species
- dog
- Participants / condition
- 45 dogs with chronic pain and radiographic OA completed
- Formulation
- Green-lipped mussel preparation, not this chew
- Studied amount, not dosing advice
- Not reported in abstract
- Duration
- 8 weeks
- Funding / conflicts
- Not reported in retrieved text
Green-lipped mussel extract in dogs with degenerative joint disease
Double-blind, placebo-controlled trial plus uncontrolled open-label extension · ingredient
Both groups improved by day 28 with no group difference. At day 56 more GLME dogs improved (p=0.018); musculoskeletal scores only marginal (p=0.053).
Limitations: Presumptive diagnosis, placebo response, subjective scoring, abstract only.
- Species
- dog
- Participants / condition
- 81 dogs presumptively diagnosed with mild-to-moderate DJD
- Formulation
- Green-lipped mussel extract, not this chew
- Studied amount, not dosing advice
- Not reported in abstract
- Duration
- 56 days controlled; 56 more days open-label
- Funding / conflicts
- Listed as non-US government research support; conflicts not reported in retrieved text
Mussel, curcumin and blackcurrant supplement in dogs and cats
Double-blind, randomised, crossover, placebo-controlled trial; only dog results used · ingredient
Veterinary COAST score improved from baseline but did not differ from placebo; no differences on owner pain index or force plate; authors called effects only partial.
Limitations: Small sample, several non-responders, blend not separable.
- Species
- dog
- Participants / condition
- 32 dogs with mild-to-moderate OA (16 cats in the study excluded here)
- Formulation
- Green-lipped mussel, curcumin and blackcurrant leaf extract blend, not this chew
- Studied amount, not dosing advice
- Not reported in the retrieved excerpt
- Duration
- 16 weeks in dogs
- Funding / conflicts
- Not reported in retrieved excerpt
Mussel plus krill oil extract (EAB-277)
Randomized, double-blind, placebo-controlled trial · ingredient
Peak vertical force and orthopedic scores better than placebo.
Limitations: Different product; short duration; dose unavailable.
- Species
- dog
- Participants / condition
- 101 pet dogs with hip OA pain
- Formulation
- Antinol Rapid mussel plus krill oil extract, not this chew
- Studied amount, not dosing advice
- Not reported in the retrieved excerpt
- Duration
- 6 weeks
- Funding / conflicts
- Funded by Pharmalink International Ltd; authors say the funder was not involved in design or analysis
"Supports post-activity or ageing recovery and long-term mobility"
No evidence found
No retrieved dog study tested recovery after activity or long-term use of this chew. Reviewed trials lasted weeks to months. Customer reviews on the page are testimonials, not evidence.
Source: PetAmaze Joint Care Daily Chews: manufacturer product page →
Signals
- Green lipped mussel is said to be 'clinically shown' to help dogs, but the page names no study.
- The label gives fish oil weight (200 mg per 2 chews), not EPA+DHA, so it can't be directly compared with the 69 mg/kg/day EPA+DHA studied in dogs (pmid27269707).
- 'Triple-A certified' silicium names no certifier, and no dog joint study of Kynosil was found in this search.
- 'Vet & Nutritionist Formulated' and 'science-backed' name no people, credentials or exact-product trial.
- Per-serving amounts for every active ingredient are printed on the label (per 2 x 2.5 g chews).
- The fish oil omega-3 percentages (57%, EPA 28%, DHA 19%) and a weight-based feeding guide are stated.
- Allergen ingredients (fish, mollusc, avian) are flagged in bold.
Dose vs studies
Label amounts at the label's daily directions, per kg of body weight, compared with what dogs studies used. This compares the label with research. It is not dosing advice.
Label: 200 mg per 2 chews · about 13.3-100 mg/kg/day
Studied: 69 mg/kg/day EPA+DHA
The label states Incromega Fish Oil; studies measured EPA+DHA.
Label: 300 mg per 2 chews
Studied: No established amount in dogs
Label: 200 mg per 2 chews
Studied: No established amount in dogs
Label: 100 mg per 2 chews
Studied: No established amount in dogs
Label: 100 mg per 2 chews
Studied: No established amount in dogs
Evidence checks
Species and formulation relevance
All dog evidence rows test a single ingredient, extract or blend at different amounts, not this chew. No exact-product trial was found in this search. The 2022 chondroitin-glucosamine review pools dogs and cats, so it is cited as context, not as a dog evidence row. Fish oil, mussel, turmeric, glucosamine and chondroitin results cannot be added together for the finished product.
Label transparency
Per-serving amounts are printed for each active, and fish oil omega-3 percentages are given. The label lists fish oil, not EPA+DHA, so the dose check was not comparable. No established dog amount was available for glucosamine, mussel, turmeric or chondroitin. The label does not state curcumin content, the mussel product type or any evidence for Kynosil.
Independent quality testing
No independent test, named third-party seal or NASC record for this company was found in the reviewed material. 'Triple-A certified' silicium appears without a named certifier. The page was reviewed as text only; label images were not independently tested.
Study quality and funding
Many cited trials were small, short or abstract-only. One mussel plus krill oil trial was funded by Pharmalink International Ltd, and most other cited trial abstracts did not report funding or conflicts. Placebo groups often improved too, so owner-reported gains must be read cautiously.
Sources (9)
- 1. PetAmaze Joint Care Daily Chews: manufacturer product page →
Manufacturer · Accessed 2026-11-06
- 2. A prospective, randomized, double blind, placebo-controlled evaluation of the effects of eicosapentaenoic acid and docosahexaenoic acid on the clinical signs and erythrocyte membrane polyunsaturated fatty acid concentrations in dogs with osteoarthritis. →
Study · Accessed 2026-11-06
- 3. A 2022 Systematic Review and Meta-Analysis of Enriched Therapeutic Diets and Nutraceuticals in Canine and Feline Osteoarthritis. →
Research review · Accessed 2026-11-06
- 4. Clinical efficacy and tolerance of an extract of green-lipped mussel (Perna canaliculus) in dogs presumptively diagnosed with degenerative joint disease. →
Study · Accessed 2026-11-06
- 5. Evaluating Complementary Therapies for Canine Osteoarthritis Part I: Green-lipped Mussel (Perna canaliculus). →
Study · Accessed 2026-11-06
- 6. The efficacy of a nutritional supplement containing green-lipped mussel, curcumin and blackcurrant leaf extract in dogs and cats with osteoarthritis. →
Study · Accessed 2026-11-06
- 7. Evaluation of the comparative efficacy of green lipped mussel plus krill oil extracts (EAB-277), <i>Biota orientalis</i> extracts or NSAIDs for the treatment of dogs with osteoarthritis associated pain: a blinded, placebo-controlled study. →
Study · Accessed 2026-11-06
- 8. Chondroprotective Effect of PCSO-524 (Green-Lipped Mussel Extraction) Application Evaluated by Ultrasonography in Pomeranian and Chihuahua With Medial Patellar Luxation Grade II. →
Study · Accessed 2026-11-06
- 9. Randomised, double-blind, placebo-controlled parallel group study of P54FP for the treatment of dogs with osteoarthritis. →
Study · Accessed 2026-11-06
How this report was produced
AI-assisted evidence analysis. We reviewed published material, not physical products.
Automated source and evidence checks completed on 2026-11-06. These checks are not veterinary review.
Research scope and outstanding checks
Searched Europe PMC-style queries for dog nutraceutical osteoarthritis reviews, the product name, MSM, Kynosil/Mesoporosil and PureFlax oil, plus the manufacturer page. Many studies were abstract-only or excerpts. Skin/coat trials, human, rodent and cat data, including mouse arms of mixed studies and the pooled dog-and-cat review, were excluded from dog evidence rows. No MSM, Kynosil or PureFlax dog joint study was retrieved. This is not an exhaustive search, and no exact-product trial was found in it.
Focused research searches:
- (TITLE_ABS:nutraceutical* AND TITLE_ABS:osteoarthrit* AND TITLE_ABS:systematic AND TITLE_ABS:review) AND (TITLE_ABS:dog OR TITLE_ABS:dogs OR TITLE_ABS:canine)
- (TITLE_ABS:nutraceutical* AND TITLE_ABS:osteoarthrit* AND TITLE_ABS:systematic AND TITLE_ABS:review) AND (TITLE_ABS:dog OR TITLE_ABS:dogs OR TITLE_ABS:canine) sort_cited:y
- (PetAmaze AND Joint AND Care AND Daily AND Chews) AND (TITLE_ABS:dog OR TITLE_ABS:dogs OR TITLE_ABS:canine)
- (PetAmaze AND Joint AND Care AND Daily AND Chews) AND (TITLE_ABS:dog OR TITLE_ABS:dogs OR TITLE_ABS:canine) sort_cited:y
- (TITLE_ABS:Methyl AND TITLE_ABS:Sulfonyl AND TITLE_ABS:Methane AND TITLE_ABS:MSM AND TITLE_ABS:osteoarthrit*) AND (TITLE_ABS:dog OR TITLE_ABS:dogs OR TITLE_ABS:canine)
- (TITLE_ABS:Methyl AND TITLE_ABS:Sulfonyl AND TITLE_ABS:Methane AND TITLE_ABS:MSM AND TITLE_ABS:osteoarthrit*) AND (TITLE_ABS:dog OR TITLE_ABS:dogs OR TITLE_ABS:canine) sort_cited:y
- (TITLE_ABS:Kynosil AND TITLE_ABS:Mesoporosil AND TITLE_ABS:osteoarthrit*) AND (TITLE_ABS:dog OR TITLE_ABS:dogs OR TITLE_ABS:canine)
- (TITLE_ABS:Kynosil AND TITLE_ABS:Mesoporosil AND TITLE_ABS:osteoarthrit*) AND (TITLE_ABS:dog OR TITLE_ABS:dogs OR TITLE_ABS:canine) sort_cited:y
- (TITLE_ABS:PureFlax AND TITLE_ABS:Oil AND TITLE_ABS:osteoarthrit*) AND (TITLE_ABS:dog OR TITLE_ABS:dogs OR TITLE_ABS:canine)
- (TITLE_ABS:PureFlax AND TITLE_ABS:Oil AND TITLE_ABS:osteoarthrit*) AND (TITLE_ABS:dog OR TITLE_ABS:dogs OR TITLE_ABS:canine) sort_cited:y
- Any trial of PetAmaze Joint Care Daily Chews itself
- The study behind the 'clinically shown' green-lipped mussel claim
- Dog joint studies of MSM, Kynosil and PureFlax oil
- Independent lab or third-party test results for this product
- Named vets or nutritionists and the basis for the formulation